Patents by Inventor James R. Boulter

James R. Boulter has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Glutamate receptor compositions and method
    Patent number: 5945509
    Abstract: The present invention discloses novel DNAs that encode proteins having electrophysiological and pharmacological properties characteristic of glutamate receptors. The glutamate receptors are exemplified by proteins encoded by representative cDNA clones GluR1, GluR2, GluR3, GluR4, GluR5, GluR6 and GluR7, fragments thereof, and functional combinations of these glutamate receptor proteins and/or fragments. DNA sequences from the cDNA clones for GluR1, GluR2, GluR3, GluR4 and GluR5 are especially useful as probes, thus enabling those skilled in the art to identify, without undue experimentation, other members of the L-glutamate receptor family.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: August 31, 1999
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James R. Boulter, Michael Hollmann, Bernhard Bettler, Jan Egebejerg Jensen
  • Glutamate receptor antibodies
    Patent number: 5739291
    Abstract: The present invention discloses novel DNAs that encode proteins having electrophysiological and pharmacological properties characteristic of glutamate receptors. The glutamate receptors are exemplified by proteins encoded by representative cDNA clones GluR1, GluR2, GluR3, GluR4, GluR5, GluR6 and GluR7, fragments thereof, and functional combinations of these glutamate receptor proteins and/or fragments. DNA sequences from the cDNA clones for GluR1, GluR2, GluR3, GluR5 and GluR5 are especially useful as probes, thus enabling those skilled in the art to identify, without undue experimentation, other members of the L-glutamate receptor family.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: April 14, 1998
    Assignee: The Salk Institute For Biological Studies
    Inventors: Stephen F. Heinemann, James R. Boulter, Michael Hollmann, Bernhard Bettler, Jan Egebejerg Jensen
  • Neuronal nicotinic acetylcholine receptor assay
    Patent number: 5591590
    Abstract: The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.
    Type: Grant
    Filed: June 6, 1995
    Date of Patent: January 7, 1997
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James W. Patrick, James R. Boulter, Evan S. Deneris, John G. Connolly, Robert M. Duvoisin, Eden D. Heinemann, Keiji Wada, Marc C. Ballivet, Daniel J. Goldman
  • Neuronal nicotinic acetylcholine receptor compositions
    Patent number: 5371188
    Abstract: The present invention relates to a family of neuronal nicotinic acetylcholine receptors comprised of neuronal agonist and non-agonist binding subunits, and DNA sequences encoding such subunits. These novel neuronal nicotinic acetylcholine receptor subunits include the agonist binding subunits alpha2, alpha3, alpha4, and alpha5, plus non-agonist binding subunits beta2, beta3 and beta4. Representative cDNA clones that contain the DNA sequences of the invention have been deposited with the American Type Culture Collection for patent purposes.
    Type: Grant
    Filed: June 12, 1992
    Date of Patent: December 6, 1994
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James W. Patrick, James R. Boulter, Evan S. Deneris, Keiji Wada, Marc C. Ballivet, Daniel J. Goldman, John G. Connolly, Robert M. Duvoisin, Eden D. Heinemann
  • Isolated nucleic acids encoding glutamate receptor protein
    Patent number: 5202257
    Abstract: The present invention discloses novel DNAs that encode proteins having electrophysiological and pharmacological properties characteristic of glutamate receptors. The glutamate receptors are exemplified by proteins encoded by representative cDNA clones GluR1, GluR2, GluR3, GluR4, GluR5, GluR6 and GluR7, fragments thereof, and functional combinations of these glutamate receptor proteins and/or fragments. DNA sequences from the cDNA clones for GluR1, GluR2, GluR3, GluR5 and GluR5 are especially useful as probes, thus enabling those skilled in the art to identify, without undue experimentation, other members of the L-glutamate receptor family.
    Type: Grant
    Filed: June 21, 1991
    Date of Patent: April 13, 1993
    Assignee: The Salk Institute for Biological Studies
    Inventors: Stephen F. Heinemann, James R. Boulter, Michael Hollmann, Bernhard Bettler, Jan E. Jensen